Pattern of HIV viraemia and CD4 levels in relation to pregnancy in HIV-1 infected women

Scandinavian Journal of Infectious Diseases

Volumn 28, Issue 5, 1996, Pages 425-433

  Lindgren, Susanne ^a   Martin, Claes ^a   Anzén, Bo ^b   Strand, Helena ^a   Bredberg Rådén, Ulla ^c,d   Ehrnst, Anneka ^a,d  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b DANDERYD HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; CD4 ANTIGEN; VIRUS DNA;

ADULT; ARTICLE; CONTROLLED STUDY; DELIVERY; DISEASE ACTIVITY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; PREGNANCY; PREGNANCY TERMINATION; RACE DIFFERENCE; SECOND TRIMESTER PREGNANCY; VIREMIA; VIRUS ACTIVATION; VIRUS CULTURE;

EID: 0029830361     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365549609037933     Document Type: Article

References (46)

1. Scott G, Fischl M, Klimas N, Fletcher M-A, Dickinson G, Levine R, Parks W. Mothers of infants with the acquired immunodeficiency syndrome. Evidence for both symptomatic and asymptomatic carriers. JAMA 253: 363-366, 1985.
2. Delfraissy J-F, Pons JC, Séréni D, Boué F, Meier D, Engelman PH, Papiernik E, Henrion R. Does pregnancy influence disease progreHIV-positive women? International Conference on the Implications of AIDS for Mothers and Children (Abstract E7). Paris, November 1989.
3. Terragna A, Anselmo M, Camera M, Canessa A, Mazzarello G, Melica F. Influence of pregnancy on disease progression in 31 HIV-infected patients. International Conference on the Implications of AIDS for Mothers and Children (Abstract E2). Paris, November 1989.
4. Lindgren S, Anzén B, Bohlin A-B, Lidman K. HIV and childbearing: clinical outcome and aspects of mother-to-infant transmission. AIDS 5: 1111-1116, 1991.
5. Hocke C, Morlat P, Chene G, Dequael L, Dabis F, and the Group d'Epidemiologie Clinique de SIDA an Aquitane. Prospective cohort study of the effect of pregnancy on the progression of human immunodeficiency virus infection. Obstet Gynecol 86: 886-891, 1995.
6. Gottlieb MS, Schroff R, Schanker HM Weisman JD, Fan PT, Wolf RA, Saxon A. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men. N Engl J Med 305: 1425-1431, 1981.
7. Masur H, Michelis MA, Greene JB, Onorato I, Stouwe RA, Holzman RS, Wormser G, Brettman L, Lange M, Murray HW, Cunningham-Rundles S. An outbreak of community-acquired pneumocystis carinii pneumonia. Initial manifestations of cellular immune dysfunction. N Engl J Med 305: 1431-1438, 1981.
8. Centers for Disease Control. Update on acquired immune deficiency syndrome (AIDS). United States, MMWR 31: 507-514, 1982.
9. Ehrnst A, Sönnerborg A, Bergdahl S, Strannegård Ö. Efficient isolation of HIV from plasma during different stages of HIV infection. J Med Virol 26: 23-32, 1988.
10. Ho DD, Moudgil T, Alam M: Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N Engl J Med 321: 1621-1625, 1989.
11. Coombs R, Collier A, Allain J-P, Nikora B, Leuther M, Gjerset G, Corey L. Plasma viremia in human immunodeficiency virus infection. N Engl J Med 321: 1626-1631, 1989.
12. Venet A, Lu W, Beldjord K, Andrieu J-M: Correlation between CD4 cell counts and cellular and plasma viral load in HIV-1-seropositive individuals. AIDS 5: 283-288, 1991.
13. Ehrnst A, Lindgren S, Dictor M, Johansson B, Sönnerborg A, Czajkowski J, Sundin G, Bohlin A-B. HIV in pregnant women and their offspring: evidence for late transmission. Lancet 338: 203-207, 1991.
14. Lyamuya E, Bredberg-Rådén U, Massawe A, Ulrassa E, Kawo G, Msemo G, Kazimoto T, Östborn A, Karlsson K, Mhalu F, Biberfeld G. Performance of a modified HIV-1 p24 antigen assay for early diagnosis of HIV-1 infection in infants and prediction of mother to infant transmission of HIV-1 in Dar Es Salaam, Tanzania. AIDS Res Hum Retroviruses 12: 421-426, 1996.
15. Lu W, Manolikakis G, Andrieu JM. Relationship between frequency of infectious human immunodeficiency virus type 1-harboring cells and kinetics of viral replication: a simple procedure for quantitation of infectious virus-carrying cells in blood samples. J Clin Microbiol 30: 2535-2538, 1992.
16. Sönnerborg A, Bergström T, Johansson B, Håkansson C, Julander I, Norkrans G, Svennerholm B, Strannegård Ö. Demonstration of HIV-1 DNA by chain reaction in immunocompetent HIV-1 antibody positive, but not in seronegative, homosexual men. Immunol Inf Dis 1: 85-89, 1991.
17. Böttiger B, Blombäck M, Berntorp E, Egberg N, Nilsson I-M, Schulman S, Stigendal L, Biberfeld G. HIV serology and lymhocyte subsets in relation to therapy and clinical development in haemophiliacs. Eur J Haematol 41: 459-466, 1988.
18. Lindgren S, Bohlin A-B, Forsgren M, Arneborn M, Ottenblad C, Lidman K, Anzén B, von Sydow M, Böttiger M. Screening for HIV-1 antibodies in pregnancy. Results from the Swedish national programme. British Med J 307: 1447-1451, 1993.
19. Baines MG, Pross HF, Millar KG. Spontanous human lymphocyte-mediated cytotoxicity against tumor target cells. The suppressive effect of normal pregnancy. Am J Obst Gyn 130: 741-744, 1978.
20. Sridama V, Pacino F, Yang S-L, Moawad A, Reilly M, de Groot L. Decreased levels of helper T-cells. A possible cause of immunodeficiency in pregnancy. N Engl J Med 307: 352-356, 1982.
21. Weinberg E. Pregnancy-associated depression of cell-mediated immunity. Rev Infect Dis 6: 814-831, 1984.
22. Degenne D, Canepa S, Lecomte C, Renoux M, Bardos P. Serial study of T-lymphocytes subsets in women during very early pregnancy. Clin Immun Immunopathol 48: 187-191, 1988.
23. Johnstone F.D, Thong K J, Graham Bird A, Whitelaw J. Lymphocyte subpopulations in early pregnancy. Obst Gyn 83: 941-946, 1994.
24. Biggar RJ, Pahwa S, Minkoff H, Mendes H, Willoughby A, Landesman S, Goedert JJ. Immunosuppression in pregnant women infected with human immunodeficiency virus. Am J Obst Gyn 161: 1239-1244, 1989.
25. Miotti P, Liomba G, Dallabetta G, Hoover D, Chiphangwi J, Saah A. T-lymphocyte subsets during and after pregnancy: analysis in human immunodeficiency virus type 1-infected and -uninfected Malawian mothers. J Infect Dis 165: 1116-1119, 1992.
26. Weedon J, Allen M, Hutchison S. Effect of pregnancy and HIV on CD4 counts in women. Second International Conference on HIV in Children and Mothers (Abstract P 1.7) Edinburgh, 1993.
27. Alger L, Farley J, Robinson B, Hines S, Berchin J, Johnson J. Interactions of human immunodeficiency virus infection and pregnancy. Obst Gyn 82: 787-796, 1993.
28. Connor E, Sperling R, Gelber R, Kiselev P, Scott G, O'Sullivan M, Van Dyke R, Bey M, Shearer W, Jacobson R, Jimenez E, O'Neill E, Bazin B, Delfraissy J-F, Culnane M, Coombs R, Elkins M, Moye J, Stratton P, Balsley J. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 331: 1173-1180, 1994.
29. Temmerman M, Nagelkerke N, Bwayo J, Chomba E, Ndinya-Achola J, Piot P. HIV-1 and immunological changes during pregnancy: A comparison between HIV-1 seropositive and HIV-1 seronegative women in Naironi, Kenya. AIDS 9: 1057-1060, 1995.
30. Lang W, Perkins H, Anderson RE, Royce R, Jewell N, Winkelstein W Jr. Pattern of T-lymphocyte changes with immunodeficiency virus infection from seroconversion to the development of AIDS. J AIDS 2: 63-66, 1989.
31. Fahey J, Taylor J Detels R, Hofmann B, Melmed R, Nisshanian P, Giorgi J. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med 322: 166-172, 1990.
32. Concorde Coordinating Committee. Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Lancet 343: 871-881, 1994.
33. Brettle R, Raab G, Ross A, Fielding K, Gore S, Bird A. HIV infection in women: immunological markers and the influence of pregnancy. AIDS 9: 1177-1184, 1995.
34. Hughes M, Stein D, Gundacker H, Valentine F, Phair J, Volberding P. Within-subject variation in CD4 lymphocyte count in asymptomatic human immunodeficiency virus infection: implications for patient monitoring. J Inf Dis 169: 28-36, 1994.
35. Reddy MM. Vodian M, Grieco MH. Elevated levels of CD4 antigen in sera of human immunodeficiency virus-infected populations. J Clin Microbiol 28: 1744-1746, 1990.
36. Dewar R, Sarmiento M, Lawton E, Clark H, Kennedy P, Shah A, Baseler M, Metcalf J, Lane H, Salzman N. Isolation of HIV-1 from plasma of infected individuals: an analysis of experimental conditions affecting successful virus propagation. J AIDS 5: 822-828, 1992.
37. Scarlatti G, Lombardi V, Plebani A, Principi N, Vegni C, Ferraris G, Bucceri A, Fenyö E-M, Wigzell H, Rossi P, Albert J. Polymerase chain reaction, virus isolation and antigen assay in HIV-1 antibody positive mothers and their children. AIDS 5: 1173-1178, 1991.
38. Henrard D, Philips J, Burchett S, Jackson B, Kataaha P, Mmiro F, Ndougwa C. Plasma viral load in symptom-free women and vertical transmission of HIV-1. Lancet 340: 1470-1471, 1992.
39. van Kerckhoven I, Fransen K, Peeters M, De Beenhouwer H, Piot P, van der Groen G. Quantification of human immunodeficiency virus in plasma by RNA PCR, viral culture, and p-24 antigen detection. J Clin Microbiol 32: 1669-1673, 1994.
40. McIntosh K, Pitt J, Brambilla D, Carroll S, Diaz C, Handelsman E, Moye J, Rich K. Blood culture in the first 6 months of life for the diagnosis of vertically transmitted human immunodeficiency virus infection. The Women and Infants Transmission Study Group. J Infect Dis 170: 996-1000, 1994.
41. Cao Y, Ho D, Todd J, Kokka R, Urdea M, Lifson J, Piatak M, Chen S, Hahn B, Saag M, Shaw G. Clinical evaluaton of branched DNA signal amplification for quantifying HIV type 1 in human plasma. AIDS Res Human Retrovir 11: 353-361, 1995.
42. Ercoli L, Sarmati L, El-Sawaf G, Cochi S, Lanti T, Iudicone P, Gugielmetti M, Giannini G, Galluzzo C, Tomino C, Andreoni M, Vella S. Plasma viremia titration and RNA quantitation in ICD-p24 - negative HIV type-1-infected patients. AIDS Res Human Retroviruses 11: 1203-1207, 1995.
43. Weiser B, Nachman S, Tropper P, Viscosi K, Grimson R, Baxter G, Fang G, Reyelt C, Hutcheon N, Burger H. Quantitation of human immunodeficiency virus type 1 during pregnancy: Relationship of viral titer to mother-to-child transmission and stability of viral load. Proc Natl Acad Sci USA 91: 8037-8041, 1994.
44. The European Collaborative Study. Clinical and immunological characteristics of HIV-1-infected pregnant women. Br J Obstet Gyn 102: 869-875, 1995.
45. Selwyn PA, Schoenbaum EE, Davenny K, Robertson VJ, Feingold AR, Schulman JF, Mayers MM, Klein RS, Friedland GH, Rogers MF. Prospective study of human immunodeficiency virus infection and pregnancy outcomes in intravenous drug users. JAMA 261: 1289-1294, 1989.
46. Deschamps M-M, Pape JW, Desvarieux M, Williams-Russo P, Madhavan S, Ho JL, Johnson WD Jr. A prospective study of HIV-seropositive asymptomatic women of childbearing age in a developing country. J AIDS 6: 446-451, 1993.